Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
Toussaint Rouamba, Esperance Ouédraogo, Houreratou Barry, Nobila Valentin Yaméogo, Apoline Sondo, Rainatou Boly, Jacques Zoungrana, Abdoul Risgou Ouédraogo, Marc Christian Tahita, Armel Poda, Arnaud Eric Diendéré, Abdoul-Salam Ouedraogo, Innocent Valea, Isidore Traoré, Zekiba Tarnagda, Maxime K Drabo, Halidou Tinto
International Journal of Infectious Diseases, doi:10.1016/j.ijid.2022.02.034
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Ousseni, Dr SOW Abobacar, Dr Seydou ZIDA, Mr BANHORO Honore Achille). The Equipe mobile team (Dr KABORE Mikaila, Dr NANA Harouna). The Clinical Research Unit of Nanoro (Mr HIEN S. Franck). The Centre Muraz/Institut National de Santé Publique team (ZOMA Aristide). Service des maladies infectieuses team (BOLY Raïnatou). Médecine Interne, Centre Hospitalier Universitaire de Sourou Sanon, Bobo-Dioulasso team (NIGNAN Issan Urbain). Service de pneumologie, Centre Hospitalier Universitaire de Sourou Sanon, Bobo-Dioulasso, Burkina Faso (OUEDRAOGO Patricia Roseline).
Competing interests The authors declare that they have no competing interests.
Ethics approval This study was approved by the National Ethics Committee (Deliberation number: 2020-000101/MS/MESRSI/CERS) and was registered on ClinicalTrials.gov (NCT04445441).
Consent for publication Not applicable.
References
Agueusia, None
Arshad, Kilgore, Chaudhry, Jacobsen, Wang et al., Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Ayerbe, Risco-Risco, Ayis, The association of treatment with hydroxychloroquine and hospital mortality in COVID-19 patients, Int J Infect Dis,
doi:10.1016/j.ijid.2020.06.099Baguiya, Poda, Cissé, Sondo, Ouedraogo et al., Effect of Hydroxychloroquine or Chloroquine and Azithromycin on COVID-19 Patients' Recovery and Mortality: Evidence from a Hospital Based Retrospective Cohort Study Conducted in Burkina Faso, J Infect Dis Epidemiol,
doi:10.23937/2474Bernaola, Mena, Bernaola, Carballo, Lara et al., Observational study of the efficiency of treatments in patients hospitalized with Covid-19 in Madrid, MedRxiv,
doi:10.1101/2020.07.17.20155960Castelnuovo, Bonaccio, Costanzo, Gialluisi, Antinori et al., Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study, Nutr Metab Cardiovasc Dis,
doi:10.1016/j.numecd.2020.07.031Catteau, Dauby, Montourcy, Bottieau, Hautekiet et al., Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants, Int J Antimicrob Agents,
doi:10.1016/j.ijantimicag.2020.106144Charlson, Szatrowski, Peterson, Validation of a combined comorbidity index, J Clin Epidemiol,
doi:10.1016/0895-4356Chen, Pan, Wu, Xiaoye, Chen et al., Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials, Eur J Clin Pharmacol,
doi:10.1007/s00228-020-02962-5Chivese, Musa, Hindy, Al-Wattary, Badran et al., Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis, Travel Med Infect Dis,
doi:10.1016/j.tmaid.2021.102135Dagens, Sigfrid, Cai, Lipworth, Cheung et al., Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: Rapid review, BMJ,
doi:10.1136/bmj.m1936Devaux, Rolain, Colson, Raoult, New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?, Int J Antimicrob Agents,
doi:10.1016/j.ijantimicag.2020.105938Elavarasi, Prasad, Seth, Sahoo, Madan et al., Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Metaanalysis, J Gen Intern Med,
doi:10.1007/s11606-020-06146-wEze, Mezue, Nduka, Obianyo, Egbuche, Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and metaanalysis of randomized controlled trials, Am J Cardiovasc Dis
Fiolet, Guihur, Rebeaud, Mulot, Peiffer-Smadja et al., Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis, Clin Microbiol Infect,
doi:10.1016/j.cmi.2020.08.022Fox, Mechanism of action of hy-droxychloroquine as an antirheumatic drug, Semin Arthritis Rheum
Gautret, Lagier, Parola, Hoang, Meddeb et al., Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study, Travel Med Infect Dis,
doi:10.1016/j.tmaid.2020.101663Gautret, Lagier, Parola, Hoang, Meddeb et al., Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents 2020a,
doi:10.1016/j.ijantimicag.2020.105949Geleris, Sun, Platt, Zucker, Baldwin et al., Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19, N Engl J Med,
doi:10.1056/nejmoa2012410Ip, Berry, Hansen, Goy, Pecora et al., Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study, PLoS One,
doi:10.1371/journal.pone.0237693Lagier, Million, Gautret, Colson, Cortaredona et al., Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis, Travel Med Infect Dis,
doi:10.1016/j.tmaid.2020.101791Lammers, Brohet, Theunissen, Koster, Rood et al., Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients, Int J Infect Dis,
doi:10.1016/j.ijid.2020.09.1460Maraolo, Grossi, Dhiver, Tomei, Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials, Rev Cardiovasc Med,
doi:10.1002/iid3.374Mittal, Mittal, Gupta, Kaushal, Chugh et al., Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19, J Fam Med Prim Care,
doi:10.4103/jfmpc.jfmpc_2338_20Pan, Peto, Karim, Alejandria, Henao-Restrepo et al., Repurposed antiviral drugs for COVID-19 -interim WHO SOLIDARITY trial results, MedRxiv,
doi:10.1101/2020.10.15.20209817Rhinorrhea, None, N
Rosenberg, Dufort, Udo, Wilberschied, Kumar et al., Association of Treatment with Hydroxychloroquine or Azithromycin with In-Hospital Mortality in Patients with COVID-19 in New York State, JAMA -J Am Med Assoc,
doi:10.1001/jama.2020.8630Rouamba, Barry, Ouédraogo, Tahita, Yaméogo et al., Safety of chloroquine or hydroxychloroquine plus azithromycin for the treatment of COVID-19 patients in Burkina Faso: An observational prospective cohort study, Ther Clin Risk Manag,
doi:10.2147/TCRM.S330813Sbidian, Josse, Lemaitre, Meyer, Bernaux et al., Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: A cohort study of 4,642 in-patients in France, MedRxiv,
doi:10.1101/2020.06.16.20132597Singh, Khan, Chowdhry, Chatterjee, Outcomes of hydroxychloroquine treatment among hospitalized COVID-19 patients in the united states-real-world evidence from a federated electronic medical record network, MedRxiv,
doi:10.1101/2020.05.12.20099028Tarnagda, Cissé, Ilboudo, Lingani, Kondombo et al., COVID-19 Outbreak in Burkina Faso: Epidemiological Surveillance among High Risk Population, EC Microbiol
Wilson, Chotirmall, Bai, Rello, COVID-19: Interim Guidance on Management Pending Empirical Evidence
Worldometer, Coronavirus Cases
Yu, Li, Chen, Li, Jiang et al., Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs, Sci China Life Sci,
doi:10.1007/s11427-020-1782-1Yu, Li, Chen, Zhou, Wang et al., Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19, Sci China Life Sci,
doi:10.1007/S11427-020-1732-2Zhaowei, Zhang, Jiang, Han, Yan et al., Efficacy of hydroxychloroquine in patients with COVID-19: results ofa randomized clinical trial, MedRixv,
doi:10.1101/2020.03.22.20040758DOI record:
{
"DOI": "10.1016/j.ijid.2022.02.034",
"ISSN": [
"1201-9712"
],
"URL": "http://dx.doi.org/10.1016/j.ijid.2022.02.034",
"alternative-id": [
"S1201971222001114"
],
"author": [
{
"ORCID": "http://orcid.org/0000-0003-0594-3887",
"affiliation": [],
"authenticated-orcid": false,
"family": "Rouamba",
"given": "Toussaint",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-1869-7200",
"affiliation": [],
"authenticated-orcid": false,
"family": "Ouédraogo",
"given": "Esperance",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0001-8114-1240",
"affiliation": [],
"authenticated-orcid": false,
"family": "Barry",
"given": "Houreratou",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Yaméogo",
"given": "Nobila Valentin",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Sondo",
"given": "Apoline",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Boly",
"given": "Rainatou",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Zoungrana",
"given": "Jacques",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ouédraogo",
"given": "Abdoul Risgou",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Tahita",
"given": "Marc Christian",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Poda",
"given": "Armel",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Diendéré",
"given": "Arnaud Eric",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Ouedraogo",
"given": "Abdoul-Salam",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-3085-0490",
"affiliation": [],
"authenticated-orcid": false,
"family": "Valea",
"given": "Innocent",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Traoré",
"given": "Isidore",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Tarnagda",
"given": "Zekiba",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Drabo",
"given": "Maxime K.",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Tinto",
"given": "Halidou",
"sequence": "additional"
}
],
"container-title": [
"International Journal of Infectious Diseases"
],
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
2,
26
]
],
"date-time": "2022-02-26T06:57:27Z",
"timestamp": 1645858647000
},
"deposited": {
"date-parts": [
[
2022,
2,
26
]
],
"date-time": "2022-02-26T06:57:28Z",
"timestamp": 1645858648000
},
"indexed": {
"date-parts": [
[
2022,
2,
26
]
],
"date-time": "2022-02-26T07:17:02Z",
"timestamp": 1645859822742
},
"is-referenced-by-count": 0,
"issn-type": [
{
"type": "print",
"value": "1201-9712"
}
],
"issued": {
"date-parts": [
[
2022,
2
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
2,
1
]
],
"date-time": "2022-02-01T00:00:00Z",
"timestamp": 1643673600000
}
},
{
"URL": "http://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 15,
"start": {
"date-parts": [
[
2022,
2,
16
]
],
"date-time": "2022-02-16T00:00:00Z",
"timestamp": 1644969600000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S1201971222001114?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S1201971222001114?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"prefix": "10.1016",
"published": {
"date-parts": [
[
2022,
2
]
]
},
"published-print": {
"date-parts": [
[
2022,
2
]
]
},
"publisher": "Elsevier BV",
"reference-count": 0,
"references-count": 0,
"relation": {},
"score": 1,
"short-container-title": [
"International Journal of Infectious Diseases"
],
"short-title": [],
"source": "Crossref",
"subject": [
"Infectious Diseases",
"Microbiology (medical)",
"General Medicine"
],
"subtitle": [],
"title": [
"Assessment of Recovery Time, Worsening and Death, among COVID-19 inpatients and outpatients, under treatment with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso"
],
"type": "journal-article"
}
